Skip to main content

Table 1 Clinical pathological data of AGC patients with synchronous liver metastasis

From: Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospectively comparative study

Clinical pathological data

Group underwent adjuvant gastrectomy

Group treated with chemotherapy only

P value

Age

61.4 ± 9.5

60.8 ± 7.9

0.834

BSA

1.758 ± 0.186

1.743 ± 0.142

0.755

Gender (male vs. female)

3.2:1

5:1

0.725

Primary tumor location

  

0.003

EGJ

4 (16.7 %)

0 (0 %)

 

U

2 (8.3 %)

9 (42.9 %)

 

M

3 (12.5 %)

5 (23.8 %)

 

L

15 (62.5 %)

7 (33.3 %)

 

Borrmann type

  

0.355

I

0 (0 %)

0 (0 %)

 

II

3 (13.6 %)

4 (21.1 %)

 

III

19 (86.4 %)

14 (73.7 %)

 

IV

0 (0 %)

1 (5.3 %)

 

Histological grade

  

0.594

Low differentiation

9 (40.9 %)

9 (45.0 %)

 

Median and low differentiation

0 (0 %)

1 (5.0 %)

 

Median differentiation

4 (18.2 %)

4 (20.0 %)

 

High and median differentiation

9 (40.9 %)

6 (30.0 %)

 

Pathological classification

  

0.273

Adenocarcinoma

22 (91.7 %)

21 (100 %)

 

Small cell carcinoma

1 (4.2 %)

0 (0 %)

 

Signet ring cell carcinoma

1 (4.2 %)

0 (0 %)

 

T stage (TNM version 7)

  

0.387

T2

3 (13.0 %)

1 (5.0 %)

 

T3

1 (4.3 %)

0 (0 %)

 

T4a

17 (73.9 %)

15 (75.0 %)

 

T4b

2 (8.7 %)

4 (20.0 %)